Ranitidine and Lipidil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Lipidil (fenofibrate). Common drug interactions include cervix inflammation among females and lower respiratory tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Lipidil. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Lipidil?

Lipidil has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 2,699 Lipidil users. Check the latest studies of Lipidil.



On Jul, 06, 2026

42 people who take Ranitidine and Lipidil together, and have interactions are studied.

Ranitidine and Lipidil drug interactions.

What are the common drug interactions of Ranitidine and Lipidil, by gender? *:

female:

  1. Cervix inflammation
  2. Chest pain
  3. Cluster headache (one-sided head pain with tearing)
  4. Death
  5. Decreased immune responsiveness
  6. Depression
  7. Diarrhoea
  8. Dihydrotestosterone decreased
  9. Drug ineffective
  10. Dry eye (lack of adequate tears)

male:

  1. Lower respiratory tract infection
  2. Abdominal pain
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Cholecystitis (infection of gallbladder)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Confusional state
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Depressed level of consciousness
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Diarrhoea

What are the common drug interactions of Ranitidine and Lipidil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

20-29:

n/a

30-39:

n/a

40-49:

  1. Hyperbilirubinaemia (excess of bilirubin in the blood)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Hyperventilation
  5. Inflammation
  6. Irritability
  7. Lymphoedema (localized fluid retention and tissue swelling)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Colitis (inflammation of colon)

60+:

  1. Abdominal pain
  2. Blood pressure fluctuation
  3. Blood pressure decreased
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Neck pain
  7. Weight decreased
  8. Anxiety disorder
  9. Arrhythmia (irregular heartbeat)
  10. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 40.48%
  2. Pain: 3 people, 7.14%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.14%
  4. High Blood Pressure: 3 people, 7.14%
  5. Growth Hormone Deficiency: 3 people, 7.14%
  6. Febrile Neutropenia (fever with reduced white blood cells): 3 people, 7.14%
  7. Back Pain: 3 people, 7.14%
  8. Abdominal Pain: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Lipidil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and fenofibrate (the active ingredients of Ranitidine and Lipidil, respectively), and Ranitidine and Lipidil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: